Literature DB >> 19013246

Chemokines in neuroectodermal tumour progression and metastasis.

Lizzia Raffaghello1, Claudia Cocco, Maria Valeria Corrias, Irma Airoldi, Vito Pistoia.   

Abstract

Chemokines and their receptors have emerged as pivotal regulators of tumour growth, progression, and metastasis. Here we review the current knowledge on chemokines and receptors likely involved in the development of metastasis of neuroectodermal tumours, with emphasis on neuroblastoma. In this respect, we discuss the controversial role of the CXCR4/CXCL12 axis in bone marrow localization of neuroblastoma cells. In addition, we focus on the ability of neuroblastoma-derived chemokines such as CCL2 and CX3CL1 to attract lymphoid cells to the tumour site. Finally, chemokine receptor and function in other neuroectodermal tumours of adulthood (i.e. melanoma and small cell lung cancer) are discussed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19013246     DOI: 10.1016/j.semcancer.2008.10.003

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  15 in total

1.  Ethanol promotes mammary tumor growth and angiogenesis: the involvement of chemoattractant factor MCP-1.

Authors:  Siying Wang; Mei Xu; Feifei Li; Xin Wang; Kimberly A Bower; Jacqueline A Frank; Yanmin Lu; Gang Chen; Zhuo Zhang; Zunji Ke; Xianglin Shi; Jia Luo
Journal:  Breast Cancer Res Treat       Date:  2011-12-09       Impact factor: 4.872

2.  An integrated proteomic approach to identifying circulating biomarkers in high-risk neuroblastoma and their potential in relapse monitoring.

Authors:  Rachel A Egler; Yiting Li; Tu Anh T Dang; Tricia L Peters; Eastwood Leung; Shixia Huang; Heidi V Russell; Hao Liu; Tsz-Kwong Man
Journal:  Proteomics Clin Appl       Date:  2011-09-07       Impact factor: 3.494

3.  Syk regulates multiple signaling pathways leading to CX3CL1 chemotaxis in macrophages.

Authors:  Haein Park; Dianne Cox
Journal:  J Biol Chem       Date:  2011-03-09       Impact factor: 5.157

4.  Lung-residing metastatic and dormant neuroblastoma cells.

Authors:  Liat Edry Botzer; Shelly Maman; Orit Sagi-Assif; Tzipi Meshel; Ido Nevo; Tobias Bäuerle; Ilana Yron; Isaac P Witz
Journal:  Am J Pathol       Date:  2011-05-03       Impact factor: 4.307

Review 5.  Chemokine signaling in cancer: one hump or two?

Authors:  Joshua B Rubin
Journal:  Semin Cancer Biol       Date:  2008-10-17       Impact factor: 15.707

Review 6.  Chemokines and the microenvironment in neuroectodermal tumor-host interaction.

Authors:  Rajasekharan Somasundaram; Dorothee Herlyn
Journal:  Semin Cancer Biol       Date:  2008-11-13       Impact factor: 15.707

Review 7.  Chemokine receptor CXCR4 as a therapeutic target for neuroectodermal tumors.

Authors:  Hyunsuk Shim; Shinya Oishi; Nobutaka Fujii
Journal:  Semin Cancer Biol       Date:  2008-11-25       Impact factor: 15.707

8.  IRF-8 controls melanoma progression by regulating the cross talk between cancer and immune cells within the tumor microenvironment.

Authors:  Fabrizio Mattei; Giovanna Schiavoni; Paola Sestili; Francesca Spadaro; Alessandra Fragale; Antonella Sistigu; Valeria Lucarini; Massimo Spada; Massimo Sanchez; Stefania Scala; Angela Battistini; Filippo Belardelli; Lucia Gabriele
Journal:  Neoplasia       Date:  2012-12       Impact factor: 5.715

9.  β-Arrestin1 and distinct CXCR4 structures are required for stromal derived factor-1 to downregulate CXCR4 cell-surface levels in neuroblastoma.

Authors:  Ian C Clift; Adebowale O Bamidele; Christie Rodriguez-Ramirez; Kimberly N Kremer; Karen E Hedin
Journal:  Mol Pharmacol       Date:  2014-01-22       Impact factor: 4.436

10.  p38MAPK inhibition: a new combined approach to reduce neuroblastoma resistance under etoposide treatment.

Authors:  B Marengo; C G De Ciucis; R Ricciarelli; A L Furfaro; R Colla; E Canepa; N Traverso; U M Marinari; M A Pronzato; C Domenicotti
Journal:  Cell Death Dis       Date:  2013-04-11       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.